Cargando…

Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4

BACKGROUND: Disordered mineral and bone metabolism is a common complication of chronic kidney disease (CKD). Bone biopsy remains the gold standard tool for evaluating renal osteodystrophy (ROD), but it is an invasive procedure. Despite a growing interest in the ability of newer bone biomarkers to di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neto, Ricardo, Pereira, Luciano, Magalhães, Juliana, Quelhas-Santos, Janete, Martins, Sandra, Carvalho, Catarina, Frazão, João Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572981/ https://www.ncbi.nlm.nih.gov/pubmed/34754436 http://dx.doi.org/10.1093/ckj/sfab081

Ejemplares similares

Could Bone Biomarkers Predict Bone Turnover after Kidney Transplantation?—A Proof-of-Concept Study
por: Magalhães, Juliana, et al.
Publicado: (2022)

Low bone turnover is associated with plain X-ray vascular calcification in predialysis patients
por: Neto, Ricardo, et al.
Publicado: (2021)

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
por: Behets, Geert J., et al.
Publicado: (2017)

Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients
por: Wu, Chun-Feng, et al.
Publicado: (2020)

COMBINING SCLEROSTIN AND DKK1 INHIBITORS TO IMPROVE BONE PROPERTIES IN THE AGED SKELETON
por: Choi, Roy, et al.
Publicado: (2022)

Role of Wnt-signaling inhibitors DKK-1 and sclerostin in bone fragility associated with Turner syndrome
por: Chiarito, M., et al.
Publicado: (2022)

Sclerostin as a novel marker of bone turnover in athletes
por: Zagrodna, A, et al.
Publicado: (2016)

Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
por: Huybrechts, Yentl, et al.
Publicado: (2023)

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
por: Florio, Monica, et al.
Publicado: (2016)

Co-expression of DKK-1 and Sclerostin in Subchondral Bone of the Proximal Femoral Heads from Osteoarthritic Hips
por: Zarei, Allahdad, et al.
Publicado: (2017)

Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged Skeleton
por: Choi, Roy B., et al.
Publicado: (2022)

Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease
por: Ivanova, Margarita M., et al.
Publicado: (2022)

Efficacy and safety of calcium carbonate in normophosphataemic patients with chronic kidney disease Stages 3 and 4
por: Neto, Ricardo, et al.
Publicado: (2019)

Changes in Dickkopf-1 (DKK1) and Sclerostin following a Loading Dose of Vitamin D(2) (300,000 IU)
por: Sankaralingam, A., et al.
Publicado: (2014)

Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases
por: Chen, Lihui, et al.
Publicado: (2022)

Circulating levels of sclerostin are associated with cardiovascular mortality
por: Novo-Rodríguez, Cristina, et al.
Publicado: (2018)

Rheumatoid arthritis is associated with increased DKK1 expression and disturbances in the bone turnover regulating genes
por: Caetano-Lopes, Joana, et al.
Publicado: (2011)

Effect of adrenocorticotropic hormone infusion on circulating sclerostin levels
por: Zaheer, Sarah, et al.
Publicado: (2021)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Regulation of Circulating Sclerostin Levels by Sex Steroids in Women and in Men
por: Mödder, Ulrike IL, et al.
Publicado: (2011)

Circulating bioactive sclerostin levels in an Austrian population-based cohort
por: Kerschan-Schindl, Katharina, et al.
Publicado: (2021)

IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
por: Jiang, Zengxin, et al.
Publicado: (2023)

Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)

Distinct roles of DKK1 and DKK2 in tumor angiogenesis
por: Park, Hongryeol, et al.
Publicado: (2013)

Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus
por: Ross, Ryan D., et al.
Publicado: (2020)

Circulating Levels of Sclerostin Predict Glycemic Improvement after Sleeve Gastrectomy
por: Carbone, Federico, et al.
Publicado: (2021)

Response of Sclerostin and Bone Turnover Markers to High Intensity Interval Exercise in Young Women: Does Impact Matter?
por: Kouvelioti, R., et al.
Publicado: (2018)

The effect of regular fitness training, sex hormones, and turnover of selected bone markers on sclerostin levels in young women
por: Plinta, Ryszard, et al.
Publicado: (2020)

Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease
por: De Maré, Annelies, et al.
Publicado: (2019)

Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes
por: Pereira, Luciano, et al.
Publicado: (2018)

Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
por: Mödder, Ulrike I, et al.
Publicado: (2011)

The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes
por: Kim, Se Hwa, et al.
Publicado: (2014)

Circulating Sclerostin and Irisin Are Related and Interact with Gender to Influence Adiposity in Adults with Prediabetes
por: Klangjareonchai, Theerawut, et al.
Publicado: (2014)

Circulating sclerostin is not suppressed following a single bout of exercise in young men
por: Guerriere, Katelyn I., et al.
Publicado: (2018)

The association of circulating sclerostin level with markers of bone metabolism in patients with thyroid dysfunction
por: Mihaljević, Olgica, et al.
Publicado: (2020)

Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
por: Choi, Hong Y., et al.
Publicado: (2009)

Serum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral Densitometry
por: Almansouri, Abdulrahman Y., et al.
Publicado: (2016)

Relationship between plasma levels of sclerostin, calcium–phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients
por: Pietrzyk, Barbara, et al.
Publicado: (2018)

Sclerostin and Vascular Pathophysiology
por: Catalano, Antonino, et al.
Publicado: (2020)

Sclerostin and Cardiovascular Disease
por: Tobias, Jonathan H.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f5vls80j1424s8o6p50flh52ka